TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment

Summary

Study to assess Pharmacodynamics, Safety, Pharmacokinetics and clinical effects of TAB08 during 12 weeks of treatment in patients with Psoriasis Vulgaris, not adequately controlled with current therapy.

Timeline

Start

2016-04

Primary completion

2016-12

Completion

2016-12

Drugs

Indications